The infusion of ex vivo, interleukin-15 and -21-activated donor NK cells after haploidentical HCT in high-risk AML and MDS patients—a randomized trial

Kyoo‐Hyung Lee, Suk Ran Yoon, Jeong‐Ryeol Gong, Eun‐Ji Choi, Hun Sik Kim, Chan‐Jeoung Park, Sung‐Cheol Yun, Soo-Yeon Park, Sol-Ji Jung, Hanna Kim, Soo Yun Lee, Haiyoung Jung, Jae‐Eun Byun, Mirang Kim, Seon‐Young Kim, Jeong‐Hwan Kim, Je‐Hwan Lee, Jung‐Hee Lee, Yunsuk Choi, Han‐Seung Park, Young‐Shin Lee, Young-Ah Kang, Mijin Jeon, Ji-Min Woo, Hyeran Kang, Seunghyun Baek, Su Mi Kim, Hoon‐Min Kim, Kwang‐Hyun Cho, Inpyo Choi